18F–fluorodeoxyglucose uptake of hepatocellular carcinoma as a prognostic predictor in patients with sorafenib treatment
出版年份 2017 全文链接
标题
18F–fluorodeoxyglucose uptake of hepatocellular carcinoma as a prognostic predictor in patients with sorafenib treatment
作者
关键词
<sup>18</sup>F–FDG pet, Prognosis, Sorafenib, Tumour response, Time to progression
出版物
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
Volume 45, Issue 3, Pages 384-391
出版商
Springer Nature
发表日期
2017-11-10
DOI
10.1007/s00259-017-3871-5
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- 18F-FDG PET/CT predicts survival after 90Y transarterial radioembolization in unresectable hepatocellular carcinoma
- (2017) Mario Jreige et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Metabolic Activity by 18F-FDG-PET/CT Is Prognostic for Stage I and II Pancreatic Cancer
- (2016) Jose M. Pimiento et al. CLINICAL NUCLEAR MEDICINE
- Prognostic value of 18F-fluorodeoxyglucose positron emission tomography/computed tomography in patients with Barcelona Clinic Liver Cancer stages 0 and A hepatocellular carcinomas: a multicenter retrospective cohort study
- (2016) Seung Hyup Hyun et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Evidence-Based Diagnosis, Staging, and Treatment of Patients With Hepatocellular Carcinoma
- (2016) Jordi Bruix et al. GASTROENTEROLOGY
- Prognostic Significance of 18F-FDG Uptake in Hepatocellular Carcinoma Treated with Transarterial Chemoembolization or Concurrent Chemoradiotherapy: A Multicenter Retrospective Cohort Study
- (2016) J. W. Lee et al. JOURNAL OF NUCLEAR MEDICINE
- 18F-FDG PET/CT Can Predict Survival of Advanced Hepatocellular Carcinoma Patients: A Multicenter Retrospective Cohort Study
- (2016) Sae Jung Na et al. JOURNAL OF NUCLEAR MEDICINE
- Real-Life Experience of Sorafenib Treatment for Hepatocellular Carcinoma in Korea: From GIDEON Data
- (2016) Do Young Kim et al. Cancer Research and Treatment
- Hepatocellular carcinoma
- (2016) Josep M. Llovet et al. Nature Reviews Disease Primers
- The predictive value of metabolic tumor volume on FDG PET/CT for transarterial chemoembolization and transarterial chemotherapy infusion in hepatocellular carcinoma patients without extrahepatic metastasis
- (2015) Jeong Won Lee et al. ANNALS OF NUCLEAR MEDICINE
- Evaluating Treatment Response of Radioembolization in Intermediate-Stage Hepatocellular Carcinoma Patients Using 18F-Fluoroethylcholine PET/CT
- (2015) M. Hartenbach et al. JOURNAL OF NUCLEAR MEDICINE
- Predictive biomarkers of sorafenib efficacy in advanced hepatocellular carcinoma: Are we getting there?
- (2015) Yu-Yun Shao WORLD JOURNAL OF GASTROENTEROLOGY
- Use of18F-FDG PET to predict tumor progression and survival in patients with intermediate hepatocellular carcinoma treated by transarterial chemoembolization
- (2015) Min Jin Kim et al. KOREAN JOURNAL OF INTERNAL MEDICINE
- A comparative study between sorafenib and hepatic arterial infusion chemotherapy for advanced hepatocellular carcinoma with portal vein tumor thrombosis
- (2014) Do Seon Song et al. JOURNAL OF GASTROENTEROLOGY
- Survival in patients with hepatocellular carcinoma treated with 90Y-microsphere radioembolization
- (2014) A. Sabet et al. NUKLEARMEDIZIN-NUCLEAR MEDICINE
- Nuclear imaging for functional evaluation and theragnosis in liver malignancy and transplantation
- (2014) Jae Seon Eo WORLD JOURNAL OF GASTROENTEROLOGY
- 18F-Fluorodeoxyglucose PET/CT predicts tumour progression after transarterial chemoembolization in hepatocellular carcinoma
- (2013) Myeong Jun Song et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- The Warburg effect: Insights from the past decade
- (2012) Mohita Upadhyay et al. PHARMACOLOGY & THERAPEUTICS
- Preoperative FDG-PET Predicts Recurrence Patterns in Hepatocellular Carcinoma
- (2011) Koji Kitamura et al. ANNALS OF SURGICAL ONCOLOGY
- Comparison of tumor response by Response Evaluation Criteria in Solid Tumors (RECIST) and modified RECIST in patients treated with sorafenib for hepatocellular carcinoma
- (2011) Julien Edeline et al. CANCER
- Prognostic value of 18F-FDG PET for hepatocellular carcinoma patients treated with sorafenib
- (2011) Jae Hoon Lee et al. LIVER INTERNATIONAL
- Modified RECIST (mRECIST) Assessment for Hepatocellular Carcinoma
- (2010) Riccardo Lencioni et al. SEMINARS IN LIVER DISEASE
- Prediction of Tumor Recurrence by 18F-FDG PET in Liver Transplantation for Hepatocellular Carcinoma
- (2009) J. W. Lee et al. JOURNAL OF NUCLEAR MEDICINE
- Increased 18F-FDG Uptake of Hepatocellular Carcinoma on Positron Emission Tomography Independently Predicts Tumor Recurrence in Liver Transplant Patients
- (2009) A. Kornberg et al. TRANSPLANTATION PROCEEDINGS
- Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial
- (2008) Ann-Lii Cheng et al. LANCET ONCOLOGY
- Sorafenib in Advanced Hepatocellular Carcinoma
- (2008) Josep M. Llovet et al. NEW ENGLAND JOURNAL OF MEDICINE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More